The next focusIR Investor Webinar takes places on 14th May with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
Terms: 1 new share in AccuStem for each Tiziana Life Sciences plc share held Ex-entitlement date: 2nd November 2020 Pay date: Upon receipt
Tiziana Life Sciences plc has announced a Demerger, whereby holders will be issued with 1 new share in AccuStem for each Tiziana Life Sciences plc share held. The ex-entitlement date is 2nd November 2020.
It is intended that AccuStem will seek admission to the standard segment of the Official List and admission to trading on the London Stock Exchange in late Q4 2020 and potentially a dual listing on NASDAQ in 2021.
Whilst the AccuStem Shares will be allotted on the completion of the Demerger, it is unlikely that the process to obtain a standard listing on the Official List and admission to trading on the London Stock Exchange will be complete by the date of completion of the Demerger. Accordingly, no AccuStem Shares will be actually issued until the earlier of AccuStem Admission; and 2 months from the date of the completion of the Demerger. This is to prevent the issue of large numbers of physical share certificates which would then need to be replaced or dematerialised upon AccuStem Admission.
LD Micro today announced the final list of companies slated to present at the upcoming LD 500, taking place September 1st-4th, 2020, exclusively online.